Abstract Rosae fructus is a traditional Chinese crude drug, used for purgative purposes. It is included in the Japanese Pharmacopoeia XV, in which its origin is stated to be Rosa multiflora Thunberg. These days, some imported Rosae fructus are on the market and the pharmacological activity of the imported product is in question. The chemical constituents of Japanese Pharmacopoeial Rosae fructus, imported from the People's Republic of China and whose plant origin is expected to be Rosa aff. multiflora, were investigated to give 2-hydroxynaringin 5-O-b-D-glucopyranoside and L(S)-pyroglutaminic acid derivative as new compounds. However, although we made every effort, the major flavonoids in R. multiflora, multiflorins A and B, and multinoside A acetate, could not be isolated.
Introduction
In Rosae fructus, some flavonol glycosides, i.e., multiflorins A and B and multinoside A and its acetate, are major constituents and play an important role in its purgative effect [1, 2] . Although the market for Rosae fructus is not very large, there are some rumors that imported Rosae fructus does not possess sufficient pharmacological activity. In this study, the chemical constituents of Japanese Pharmacopoeial Rosae fructus, imported from the People's Republic of China, are investigated.
Results and discussion
From Rosae fructus, imported from the People's Republic of China, two new compounds (1 and 2) (Fig. 1 ) along with a methyl ester of 2 (3), which must be formed during isolation, quercetin (4) [3] , seven flavonoid glycosides, multinoside A (5) [3] , isoquercitrin (6) [3] , quercetin 3-O-b-D-glucuronide methyl ester (7) [4] , hyperin (8) [3] , isorhamnetin 3-O-b-D-glucoside (9) [5, 6] , taxifolin 3-O-b-D-xylopyranoside (10) [7] , heliocioside A (11) [8] , syringin (12) [9, 10] , (6S,9R)-roseoside (13) [11] , and 9 0 -tetrahydroxy-3-methoxy-8-O-4 0 -neolignane 3 0 -O-b-D-glucopyranoside (14) [12] were isolated by means of various chromatographic techniques. The known compounds were identified by spectroscopical comparison with data reported in the literature.
2-Hydroxynaringin 5-O-b-D-glucopyranoside (1),
[a] D -61.7, was isolated as an amorphous powder and its elemental composition was determined to be C 21 H 22 O 11 on negative-ion HR-FAB-MS. In the IR spectrum, absorption bands for hydroxyl groups (3,344 cm -1 ), a conjugated carbonyl group (1,689 cm -1 ), and aromatic rings (1,618 and 1,514 cm -1 ) were observed. The UV absorption maxima indicated the phenolic feature of 1. In the 13 C-NMR spectrum, some signals appeared as dual peaks in the ratio of nearly 1:1 (Table 1) (Fig. 2) . The position of the sugar linkage was established to be on the hydroxyl group at C-5, based on the HMBC correlation from the anomeric proton [d H 4.87 (4.85)] to C-5 [d C 158.41 (158.29)]. This was further confirmed by the differential NOE experiment, in which irradiation of the anomeric proton significantly enhanced the peak area of the H-6 signal [d H 6.06 (6.05)]. The mode of the sugar linkage was determined to be b from the coupling constants (8 Hz) of the anomeric proton, and the absolute configuration of glucose was established to be of the D-series from the results of chirality analysis of the hydrolyzate of 1. Therefore, the structure of 1 was elucidated to be 2-hydroxynaringin 5-O-b-D-glucopyranoside, as shown in Fig. 1 . 2-Hydroxynaringin exists as an interconvertible epimeric mixture of hemiketal and 1,3-diketone forms [13] [14] [15] . However, based on the mass spectral and NMR data, the hemiketal form was dominant.
Compound 2, [a] D 21 ?30.3, was isolated as an amorphous powder, but its elemental composition could not be determined since no molecular ion peak was observed in the high-resolution electrospray time-of-flight mass spectrum (HR-ESI-TOF-MS) or on HR-FAB-MS. The IR spectrum showed strong absorption bands at 3,395 cm -1 for a hydroxyl group, which tailed to around 2,500 cm -1 , at 1,651 cm -1 for an amide carbonyl group, and at 1,590 cm
for a carboxylate carbonyl group. From this evidence, compound 2 was implied to be present as a zwitterion. In the 13 C-NMR spectrum together with the 1 H-NMR spectrum, carbon signals for two carbonyl carbons, one monosubstituted benzene ring, three methylenes, and two methines with electronegative substituents were observed. The methylene signal at d C 51.5 suggested that compound 2 contained a (Fig. 3) , the planar structure could not be elucidated. Thus, compound 2 was reacted with p-bromophenacyl bromide to yield the p-bromophenacyl ester of 2 (2a), which gave a suitable crystal for X-ray crystallographic analysis. The structure of compound 2a was confirmed to be N-7-hydroxyphenylethynyl L(S)-pyroglutamic acid, as shown by the ORTEP drawing in Fig. 4 . Therefore, the structure of 2 was elucidated to be a free acid form of 2a.
Compound 3, [a] D 29 ?17.8, was isolated as an amorphous powder and its elemental composition was determined to be C 14 H 17 O 4 N on HR-ESI-TOF-MS. The 1 H-and 13 C-NMR spectra showed that compound 3 was an analogous compound to 2, except for the presence of a methoxy signal at d H 3.76 on d C 53.0. Thus, the structure of 2 was elucidated to be the methyl ester of 2. This compound may be formed during extraction and isolation due to exposure to methanolic conditions.
Although the isolation work was extensive, only multinoside A (5) (0.01%) was isolated, and multiflorins A and B and multinoside A acetate have so far not been isolated. Until Japanese Pharmacopoeia XIV, the origin of Rosae fructus was stated to be the fruit of Rosa mutiflora Thun. or a related species, R. wichuraiana Crépin. However, in the current Japanese Pharmacopoeia XV, R. wichuraiana is excluded, following the research finding by Seto et al. that no pharmacologically active principles are included in R. wichuraiana [3] . Thus, the imported Rosae fructus used in this study, although it was available as a Japanese Pharmacopoeially compatible material, cannot be R. multiflora, which is the only species in the current Japanese Pharmacopoeia. The results of qualitative analysis of the flavonoid glycoside contents of Rosae fructus, obtained from several sources, and genetic investigation will appear elsewhere.
Experimental

General experimental procedures
Mps were measured with a Yanagimoto micromelting point apparatus and are uncorrected. Optical rotations were measured on a JASCO P-1030 polarimeter. IR and UV spectra were measured on Horiba FT-710 and JASCO V-520 UV/ VIS spectrophotometers, respectively.
1 H-and 13 C-NMR spectra were taken on a JEOL JNM a-400 spectrometer at 400 and 100 MHz, respectively, with tetramethylsilane as the internal standard. Positive-ion HR-FAB-MS was performed with a JEOL SX-102 spectrometer and an Applied Biosystem QSTAR XL system ESI (Nano Spray)-TOF mass spectrometer.
A highly porous synthetic resin (Diaion HP-20) was purchased from Mitsubishi Kagaku (Tokyo, Japan). Silica gel column chromatography (CC) and reversed-phase phases, respectively. Five-gram fractions were collected and numbered according to their order of elution with the mobile phase. HPLC was performed on an ODS-3 column (Inertsil; GL Science, Tokyo, Japan; U = 6 mm, L = 25 cm), and the eluate was monitored with a UV detector at 254 nm and a refractive index monitor.
Plant material
Rosae fructus, purchased from a crude drug store in Hiroshima, was imported from the People's Republic of China by Kinokuniya Kan-yakkyoku (Tokyo, Japan).
Extraction and isolation
Rosae fructus (5.0 k) was crushed and extracted three times with MeOH (15 l) at 25°C for 1 week and then concentrated to 3 l in vacuo. The extract was washed with nhexane (3 l, 35.4 g) and then the MeOH layer was concentrated to a gummy mass. The latter was suspended in water (3 l) and then extracted with EtOAc (3 l) to give 24.7 g of an EtOAc-soluble fraction. The aqueous layer was extracted with 1-BuOH (3 l) to give a 1-BuOH-soluble fraction (106 g), and the remaining water-layer was concentrated to furnish 475 g of a water-soluble fraction. 
Preparation of p-bromophenacyl ester (2a)
Compound 2 (18.3 mg) was dissolved in 1.0 ml of EtOH and the solution was made slight basic by means of 0.1 N NaOH with a few drops of phenol phthalein solution as an indicator. After the addition of a small amount (2.0 mg) of 2, p-bromophenacyl bromide (25.3 mg) in 1.0 ml of EtOH was added, followed by refluxing for 9 h. After cooling, the solvent was evaporated off and the residue was purified by silica gel CC (U = 1.0 cm, L = 40 cm) with CHCl 3 (50 ml) and then CHCl 3 -MeOH (49:1, 150 ml) (1-ml fractions being collected) to give crude crystals in fractions 138-175, which were then recrystallized from MeOH to give 10. Single-crystal X-ray structure analysis of 2a A suitable crystal (0.43 9 0.30 9 0.05 mm) was used for analysis. The data were measured using a Bruker SMART 1000 CCD diffractometer, using Mo Ka graphite-monochromated radiation (k = 0.71073 Å ). The structure was solved by a direct method using the program SHELXTL-97 [16] . The refinement and all further calculations were carried out using SHELXTL-97 [16] . The absorption correction was carried out utilizing the SADABS routine [17] . The H atoms were included at calculated positions and treated as riding atoms using the SHELXTL default parameters. The non-H atoms were refined anisotropically, using weighted full-matrix least-squares on F 2 . Figure , l(Mo Ka) = 2.130 mm -1 , F(000) = 456; 3,296 reflections were measured, 2,805 were unique (R int = 0.0468) and used in all calculations. Final goodness-of-fit = 1.017, R 1 = 0.0502, wR 2 = 0.1175 based on I [ 2r(I). The absolute parameter was 0.014(13) [19] . CCDC deposit contains the supplementary crystallographic data. These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax: ?44-1223-336033; or e-mail: deposit@ccdc.cam.ac.uk.
